株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

能動埋め込み型医療機器 (AMID) の世界市場 - 2022年までの予測:植え込み型除細動器 (ICD)、心臓ペースメーカー、補助人工心臓 (VAD)、神経刺激装置、人工内耳

Active Implantable Medical Devices Market by Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices) - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 487280
出版日 ページ情報 英文 207 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.56円で換算しております。
Back to Top
能動埋め込み型医療機器 (AMID) の世界市場 - 2022年までの予測:植え込み型除細動器 (ICD)、心臓ペースメーカー、補助人工心臓 (VAD)、神経刺激装置、人工内耳 Active Implantable Medical Devices Market by Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices) - Global Forecast to 2022
出版日: 2017年04月05日 ページ情報: 英文 207 Pages
概要

能動埋め込み型医療機器 (AMID) 市場は、2017年の184億2000万米ドルから、2022年までに267億5000万米ドルまで拡大すると見られています。市場は、2016年~2022年のCAGR (複合年間成長率) で、7.8%の成長が予測されています。

当レポートでは、世界の能動埋め込み型医療機器 (AMID) 市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

FIGURE 10 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 能動埋め込み型医療機器 (AMID) :市場スナップショット
  • 欧州:能動埋め込み型医療機器 (AMID) 市場、製品別
  • 能動埋め込み型医療機器 (AMID) 市場:地域別の成長機会
  • 能動埋め込み型医療機器 (AMID) 市場:地域構成
  • 能動埋め込み型医療機器 (AMID) 市場:発展途上 vs. 先進国/地域

第5章 能動埋め込み型医療機器 (AMID) の世界市場:概要

  • イントロダクション
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場の機会
    • 市場の課題

第6章 能動埋め込み型医療機器 (AMID) の世界市場:産業考察

  • イントロダクション
  • 主な産業動向
  • 規制分析

第7章 能動埋め込み型医療機器 (AMID) の世界市場:製品別

  • イントロダクション
  • 植え込み型除細動器 (ICD)
  • 植え込み型心臓ペースメーカー
  • 補助人工心臓 (VAD)
  • 植え込み型心臓モニター/ループレコーダー
  • 神経刺激装置
  • 人工内耳

第8章 能動埋め込み型医療機器 (AMID) の世界市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合状況と動向

第10章 企業プロファイル

  • イントロダクション
  • ABBOTT LABORATORIES
  • MEDTRONIC PLC
  • BOSTON SCIENTIFIC CORPORATION
  • BIOTRONIK SE & CO., KG
  • LIVANOVA PLC
  • WILLIAM DEMANT HOLDING A/S
  • COCHLEAR LIMITED
  • SONOVA HOLDING AG
  • MED-EL
  • NUROTRON BIOTECHNOLOGY CO. LTD.

第11章 付録

目次
Product Code: MD 5150

The active implantable medical devices market is estimated to grow at a CAGR of 7.8% from 2017 to 2022, to reach USD 26.75 billion by 2022 from USD 18.42 billion in 2017. The growth of this market is mainly attributed to the rising aging population, increasing prevalence of cardiovascular and neurological diseases, investments and funds to develop technologically advanced products, expanded applications of neurostimulators, and favorable reimbursement scenario for ENT procedures in developed countries. However, unfavorable healthcare reforms in the U.S., issues related to the use of implantable medical devices, and the high cost of cardiac and neurostimulators implantable devices may hinder the growth of this market to a certain extent during the forecast period. Growth opportunities in the emerging markets and the development of subcutaneous implantable cardioverter defibrillators offer significant growth opportunities in this market.

In this report, the active implantable medical devices market is segmented on the basis of product and region. On the basis of product, the market is segmented into implantable cardioverter defibrillators, implantable cardiac pacemakers, implantable heart monitors/insertable loop recorders, ventricular assist devices, neurostimulators, and implantable hearing devices. The Implantable hearing devices segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is primarily attributed to the increasing prevalence of hearing loss across the globe and growing ENT procedures due to favorable reimbursement policies in the developed countries.

Geographically, North America commanded a major share of the active implantable medical devices market in 2016. Factors such as growth in geriatric population, increasing prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, increasing development of innovative and technologically advanced products, and increasing healthcare expenditure in the region are contributing to the large share of North America. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the rising geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies to develop advanced products, and less stringent regulations in this region.

Some of the prominent players in the implantable cardiovascular devices market include Medtronic plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), and LivaNova PLC (U.K.); whereas, Cochlear Limited (Australia), MED-EL (Austria), Sonova Holding AG (Switzerland), William Demant Holding A/S (Denmark), and Nurotron Biotechnology Co., Ltd. (China) are the key players in the implantable hearing devices market.

Research Coverage:

The report analyzes the various type of active implantable medical devices provided by medical device manufacturers across the globe. It aims at estimating the market size and future growth potential of the active implantable medical devices market for different products and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product portfolio, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the active implantable medical devices market. The report analyzes the active implantable medical devices market by product and region
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the active implantable medical devices market
  • Market Development: Comprehensive information about the lucrative emerging markets by product and region
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the active implantable medical devices market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and manufacturing capabilities of leading players in the active implantable medical devices market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
    • 2.1.1. SECONDARY SOURCES
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY SOURCES
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ACTIVE IMPLANTABLE MEDICAL DEVICES: MARKET SNAPSHOT
  • 4.2. EUROPE: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT
  • 4.3. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: GEOGRAPHIC MIX
  • 4.5. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES/REGIONS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Increasing burden of cardiovascular diseases
      • 5.2.1.2. Rising prevalence of neurological disorders
      • 5.2.1.3. Investments and funds to develop technologically advanced products
      • 5.2.1.4. Expanded applications of neurostimulators
      • 5.2.1.5. Favorable reimbursement scenario for ent procedures in developed countries
    • 5.2.2. MARKET RESTRAINTS
      • 5.2.2.1. Unfavorable healthcare reforms in the U.S.
      • 5.2.2.2. Issues related to the use of implantable medical devices
      • 5.2.2.3. High cost of implants and an unfavorable reimbursement scenario
    • 5.2.3. MARKET OPPORTUNITIES
      • 5.2.3.1. Emerging markets offer significant growth opportunities
      • 5.2.3.2. Development of subcutaneous implantable cardioverter defibrillators (S-ICDs)
    • 5.2.4. MARKET CHALLENGES
      • 5.2.4.1. Increasing pricing pressure on market players
      • 5.2.4.2. Dearth of skilled professionals

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. KEY INDUSTRY TRENDS
    • 6.2.1. INCREASING MARKET CONSOLIDATION
    • 6.2.2. DEVELOPMENT OF INNOVATIVE, EASY-TO-USE IMPLANTABLE CARDIOVASCULAR PRODUCTS WITH INCREASED LONGEVITY
    • 6.2.3. DEVELOPMENT OF TECHNOLOGICALLY ADVANCED IMPLANTABLE HEARING DEVICES AND EXPANSION OF DISTRIBUTION CHANNEL FOR HEARING IMPLANTS
  • 6.3. REGULATORY ANALYSIS
    • 6.3.1. NORTH AMERICA
      • 6.3.1.1. U.S.
      • 6.3.1.2. Canada
    • 6.3.2. EUROPE
    • 6.3.3. ASIA-PACIFIC
      • 6.3.3.1. Japan
      • 6.3.3.2. China
      • 6.3.3.3. India
    • 6.3.4. REST OF THE WORLD

7. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
    • 7.2.1. TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
      • 7.2.1.1. Biventricular implantable cardioverter defibrillators (ICDs)/cardiac resynchronization therapy defibrillators (CRT-Ds)
      • 7.2.1.2. Dual-chamber implantable cardioverter defibrillators
      • 7.2.1.3. Single-chamber implantable cardioverter defibrillators
    • 7.2.2. SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
  • 7.3. IMPLANTABLE CARDIAC PACEMAKERS
  • 7.4. VENTRICULAR ASSIST DEVICES
  • 7.5. IMPLANTABLE HEART MONITORS/INSERTABLE LOOP RECORDERS
  • 7.6. NEUROSTIMULATORS
    • 7.6.1. SPINAL CORD STIMULATORS
    • 7.6.2. DEEP BRAIN STIMULATORS
    • 7.6.3. SACRAL NERVE STIMULATORS
    • 7.6.4. VAGUS NERVE STIMULATORS
    • 7.6.5. GASTRIC ELECTRICAL STIMULATORS
  • 7.7. IMPLANTABLE HEARING DEVICES
    • 7.7.1. ACTIVE HEARING IMPLANTS
    • 7.7.2. PASSIVE HEARING IMPLANTS

8. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. U.S.
    • 8.2.2. CANADA
  • 8.3. EUROPE
    • 8.3.1. GERMANY
    • 8.3.2. U.K.
    • 8.3.3. FRANCE
    • 8.3.4. ITALY
    • 8.3.5. SPAIN
    • 8.3.6. REST OF EUROPE (ROE)
  • 8.4. ASIA-PACIFIC
    • 8.4.1. JAPAN
    • 8.4.2. CHINA
    • 8.4.3. INDIA
    • 8.4.4. REST OF ASIA-PACIFIC (RO-APAC)
  • 8.5. LATIN AMERICA
  • 8.6. MIDDLE EAST AND AFRICA

9. COMPETITIVE LANDSCAPE

  • 9.1. OVERVIEW
  • 9.2. MARKET SHARE ANALYSIS
  • 9.3. COMPETITIVE SITUATIONS AND TRENDS
    • 9.3.1. PRODUCT LAUNCHES
    • 9.3.2. MERGERS & ACQUISITIONS
    • 9.3.3. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 9.3.4. EXPANSIONS

10. COMPANY PROFILES (OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*

  • 10.1. INTRODUCTION
  • 10.2. ABBOTT LABORATORIES
  • 10.3. MEDTRONIC PLC
  • 10.4. BOSTON SCIENTIFIC CORPORATION
  • 10.5. BIOTRONIK SE & CO., KG
  • 10.6. LIVANOVA PLC
  • 10.7. WILLIAM DEMANT HOLDING A/S
  • 10.8. COCHLEAR LIMITED
  • 10.9. SONOVA HOLDING AG
  • 10.10. MED-EL
  • 10.11. NUROTRON BIOTECHNOLOGY CO. LTD.

Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

11. APPENDIX

  • 11.1. INSIGHTS OF INDUSTRY EXPERTS
  • 11.2. DISCUSSION GUIDE
  • 11.3. OTHER DEVELOPMENTS
  • 11.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.5. AVAILABLE CUSTOMIZATIONS
  • 11.6. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 11.7. RELATED REPORTS
  • 11.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: TOTAL NUMBER OF CVD-RELATED DEATHS, BY CAUSE AND LATEST AVAILABLE YEAR IN EUROPE
  • TABLE 2: NUMBER OF NEUROLOGICAL DISORDERS AS A PERCENTAGE OF GLOBAL DALYS (2005, 2015, & 2030)
  • TABLE 3: NEUROSTIMULATION TECHNIQUES FOR DIFFERENT INDICATIONS
  • TABLE 4: MARKET DRIVERS: IMPACT ANALYSIS
  • TABLE 5: MARKET RESTRAINTS: IMPACT ANALYSIS
  • TABLE 6: MARKET OPPORTUNITIES: IMPACT ANALYSIS
  • TABLE 7: MARKET CHALLENGES: IMPACT ANALYSIS
  • TABLE 8: MAJOR MERGERS & ACQUISITIONS IN THE ACTIVE IMPLANTABLE MEDICAL DEVICES INDUSTRY (2014-2017)
  • TABLE 9: STRINGENCY OF REGULATIONS FOR IMPLANTABLE MEDICAL DEVICES, BY REGION
  • TABLE 10: GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 11: GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 12: GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
  • TABLE 13: GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 14: GLOBAL TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
  • TABLE 15: GLOBAL TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 16: EUROPE: NUMBER OF CRT-D UNITS IMPLANTED, BY COUNTRY, 2014 & 2015
  • TABLE 17: ASIA: NUMBER OF CRT-D UNITS IMPLANTED, BY COUNTRY, 2011-2013
  • TABLE 18: BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 19: DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 20: SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 21: SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 22: EUROPE: NUMBER OF PACEMAKER UNITS IMPLANTED, BY COUNTRY (2013-2015)
  • TABLE 23: ASIA-PACIFIC: PACEMAKER IMPLANTATION RATE, BY COUNTRY, 2013
  • TABLE 24: GLOBAL IMPLANTABLE CARDIAC PACEMAKERS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 25: VENTRICULAR ASSIST DEVICES MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 26: IMPLANTABLE HEART MONITORS/INSERTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 27: NEUROSTIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
  • TABLE 28: NEUROSTIMULATORS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 29: SPINAL CORD STIMULATORS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 30: DEEP BRAIN STIMULATORS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 31: SACRAL NERVE STIMULATORS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 32: VAGUS NERVE STIMULATORS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 33: GASTRIC ELECTRICAL STIMULATORS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 34: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
  • TABLE 35: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 36: ACTIVE HEARING IMPLANTS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 37: PASSIVE HEARING IMPLANTS MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 38: GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 39: NORTH AMERICA: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 40: NORTH AMERICA: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 41: NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 42: NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 43: NORTH AMERICA: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 44: NORTH AMERICA: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 45: INDICATORS FOR THE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET IN THE U.S.
  • TABLE 46: U.S.: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 47: U.S.: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 48: U.S.: TRANSVENOUS IMPLANTABLE CARIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 49: U.S.: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 50: U.S.: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: INDICATORS FOR THE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET IN CANADA
  • TABLE 52: CANADA: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 53: CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 54: CANADA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: CANADA: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 56: CANADA: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 57: TOTAL NUMBER OF DEATHS BY CARDIOVASCULAR DISEASES IN THE EUROPEAN REGION
  • TABLE 58: PREVALENCE OF DEMENTIA IN EUROPE (2013)
  • TABLE 59: EUROPE: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 60: EUROPE: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 61: EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 62: EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 63: EUROPE: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: EUROPE: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 65: INDICATORS FOR THE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET IN GERMANY
  • TABLE 66: GERMANY: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 67: GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: GERMANY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 69: GERMANY: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 70: GERMANY: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 71: CVD MORTALITY STATISTICS (2015)
  • TABLE 72: INDICATORS FOR THE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET IN THE U.K.
  • TABLE 73: U.K.: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 74: U.K.: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 75: U.K.: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 76: U.K.: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 77: U.K.: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 78: NUMBER OF DEATHS UNDER 75 YEARS IN FRANCE (2013)
  • TABLE 79: INDICATORS FOR THE MEDICAL IMPLANTBLE AND LIFE-SUSTAINING DEVICES MARKET IN FRANCE
  • TABLE 80: FRANCE: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 81: FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 82: FRANCE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 83: FRANCE: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 84: FRANCE: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 85: TOTAL NUMBER OF DEATHS BY CARDIOVASCULAR DISEASES IN ITALY (2012)
  • TABLE 86: INDICATORS FOR THE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET IN ITALY
  • TABLE 87: ITALY: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 88: ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 89: ITALY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 90: ITALY: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 91: ITALY: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 92: TOTAL NUMBER OF CVD-RELATED DEATHS IN SPAIN (2009 VS. 2014)
  • TABLE 93: INDICATORS FOR THE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET IN SPAIN
  • TABLE 94: SPAIN: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 95: SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 96: SPAIN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORSMARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 97: SPAIN: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 98: SPAIN: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 99: TOTAL NUMBER OF DEATHS BY CARDIOVASCULAR DISEASES IN ROE COUNTRIES
  • TABLE 100: PREVALENCE OF DEMENTIA IN ROE COUNTRIES (2013)
  • TABLE 101: STATISTICS FOR IMPLANTATION IN ROE COUNTRIES (2013 & 2015)
  • TABLE 102: ROE: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 103: ROE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 104: ROE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 105: ROE: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 106: ROE: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 107: CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE IMPLANTATION RATES AND IMPLANTING CENTERS PER MILLION INHABITANTS, 2013 VS. 2014
  • TABLE 108: ASIA-PACIFIC: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 109: ASIA-PACIFIC: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 110: ASIA-PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 111: ASIA-PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 112: ASIA-PACIFIC: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 113: ASIA-PACIFIC: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 114: INDICATORS FOR ACTIVE IMPLANTABLE MEDICAL DEVICES IN JAPAN (2013-2015)
  • TABLE 115: JAPAN: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 116: JAPAN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 117: JAPAN: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 118: JAPAN: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 119: INDICATORS FOR MEDICAL IMPLANTABLE AND LIFE SUSTAINING DEVICES IN CHINA (2013-2015)
  • TABLE 120: CHINA: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 121: CHINA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 122: CHINA: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 123: CHINA: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 124: INDICATORS FOR ACTIVE IMPLANTABLE MEDICAL DEVICES IN INDIA (2012-2014)
  • TABLE 125: INDIA: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 126: INDIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 127: INDIA: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 128: INDIA: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 129: NUMBER OF DEATHS FROM CARDIOVASCULAR DISEASES IN SINGAPORE (2013-2015)
  • TABLE 130: INDICATORS FOR MEDICAL IMPLANTABLE AND LIFE SUSTAINING DEVICES IN ROAPAC (2015)
  • TABLE 131: ROAPAC: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 132: ROAPAC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 133: ROAPAC: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 134: ROAPAC: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 135: NUMBER OF PEOPLE WITH DEMENTIA IN LATIN AMERICA
  • TABLE 136: LATIN AMERICA: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 137: LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 138: LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 139: LATIN AMERICA: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 140: LATIN AMERICA: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 141: INDICATORS FOR THE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET IN THE MIDDLE EAST AND AFRICA
  • TABLE 142: MIDDLE EAST AND AFRICA: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 143: MIDDLE EAST AND AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 144: MIDDLE EAST AND AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 145: MIDDLE EAST AND AFRICA: NEUROSTIMULATORS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 146: MIDDLE EAST AND AFRICA: IMPLANTABLE HEARING DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 147: GROWTH STRATEGY MATRIX, 2014-2017
  • TABLE 148: PRODUCT LAUNCHES, 2014-2017
  • TABLE 149: MERGERS & ACQUISITIONS, 2014-2017
  • TABLE 150: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2014-2017
  • TABLE 151: EXPANSIONS, 2014-2017

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
  • FIGURE 7: GEOGRAPHIC SNAPSHOT OF THE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, 2016
  • FIGURE 8: GROWTH STRATEGY MATRIX OF THE TOP 3 PLAYERS IN THE GLOBAL IMPLANTABLE CARDIOVASCULAR AND NEUROSTIMULATOR DEVICES MARKET (2014-2017)
  • FIGURE 9: GROWTH STRATEGY MATRIX OF THE TOP 3 PLAYERS IN THE GLOBAL IMPLANTABLE HEARING DEVICES MARKET (2014-2017)
  • FIGURE 10: INCREASING PREVALENCE OF CARDIOVASCULAR AND NEUROLOGICAL DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 11: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS SEGMENT DOMINATED THE EUROPEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET IN 2016
  • FIGURE 12: THE U.S. WAS THE LARGEST MARKET FOR ACTIVE IMPLANTABLE MEDICAL DEVICES IN 2016
  • FIGURE 13: APAC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 14: CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: IMPLANTABLE AND LIFE-SUSTAINING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: DEVELOPMENT OF TECHNOLOGICALLY ADVANCED IMPLANTABLE DEVICES AND RISING NUMBER OF MERGERS AND ACQUISITIONS AMONG MARKET PLAYERS ARE THE LEADING INDUSTRY TRENDS
  • FIGURE 17: GEOGRAPHIC SNAPSHOT (2016) - RAPID GROWTH MARKETS ARE EMERGING AS NEW HOTSPOTS
  • FIGURE 18: NORTH AMERICAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SNAPSHOT
  • FIGURE 19: APAC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SNAPSHOT
  • FIGURE 20: PRODUCT LAUNCHES-KEY GROWTH STRATEGY PURSUED BY MARKET PLAYERS BETWEEN 2014 AND 2017
  • FIGURE 21: GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 22: GLOBAL IMPLANTABLE CARDIAC PACEMAKERS MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 23: GLOBAL IMPLANTABLE NEUROSTIMULATORS MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 24: GLOBAL IMPLANTABLE HEARING DEVICES MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 25: BATTLE FOR MARKET SHARE: PRODUCT LUNCHES, THE KEY STRATEGY
  • FIGURE 26: GEOGRAPHIC REVENUE MIX OF THE TOP 4 PLAYERS IN THE IMPLANTABLE CARDIOVASCULAR AND NEUROSTIMULATOR DEVICES MARKET
  • FIGURE 27: GEOGRAPHIC REVENUE MIX OF THE TOP 3 PLAYERS IN THE IMPLANTABLE HEARING DEVICES MARKET
  • FIGURE 28: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2015)
  • FIGURE 29: MEDTRONIC PLC: COMPANY SNAPSHOT (2016)
  • FIGURE 30: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 31: LIVANOVA PLC: COMPANY SNAPSHOT (2015)
  • FIGURE 32: WILLIAM DEMANT HOLDING A/S: COMPANY SNAPSHOT (2015)
  • FIGURE 33: COCHLEAR LIMITED: COMPANY SNAPSHOT (2016)
  • FIGURE 34: SONOVA HOLDING AG: COMPANY SNAPSHOT (2016)
Back to Top